6AC5

Crystal structure of RIPK1 death domain GlcNAcylated by EPEC effector NleB

6AC5 の概要

• エントリーDOI: 10.2210/pdb6ac5/pdb
• 関連するPDBエントリー: 6AC0
• 分子名称: Receptor-interacting serine/threonine-protein kinase 1, 2-acetamido-2-deoxy-beta-D-glucopyranose, SULFATE ION, ... (4 entities in total)
• 機能のキーワード: apoptosis, signaling protein
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 13256.88

構造登録者

Ding, J.,Shao, F. (登録日: 2018-07-25, 公開日: 2019-05-01, 最終更新日: 2024-10-23)

主引用文献

Ding, J.,Pan, X.,Du, L.,Yao, Q.,Xue, J.,Yao, H.,Wang, D.C.,Li, S.,Shao, F.
Structural and Functional Insights into Host Death Domains Inactivation by the Bacterial Arginine GlcNAcyltransferase Effector.
Mol.Cell, 74:922-, 2019

PubMed Abstract: Enteropathogenic E. coli NleB and related type III effectors catalyze arginine GlcNAcylation of death domain (DD) proteins to block host defense, but the underlying mechanism is unknown. Here we solve crystal structures of NleB alone and in complex with FADD-DD, UDP, and Mn as well as NleB-GlcNAcylated DDs of TRADD and RIPK1. NleB adopts a GT-A fold with a unique helix-pair insertion to hold FADD-DD; the interface contacts explain the selectivity of NleB for certain DDs. The acceptor arginine is fixed into a cleft, in which Glu253 serves as a base to activate the guanidinium. Analyses of the enzyme-substrate complex and the product structures reveal an inverting sugar-transfer reaction and a detailed catalytic mechanism. These structural insights are validated by mutagenesis analyses of NleB-mediated GlcNAcylation in vitro and its function in mouse infection. Our study builds a structural framework for understanding of NleB-catalyzed arginine GlcNAcylation of host death domain.

PubMed: 30979585
DOI: 10.1016/j.molcel.2019.03.028

実験手法

X-RAY DIFFRACTION (1.451 Å)